[30-416-pm] Diseases and therapies of central nervous system 1

Sat. Mar 30, 2024 1:15 PM - 2:15 PM [Room 416] Conference Center 416 (4F)

Chair: Shirakawa Hisashi, Daisuke Ibi

+Add all to schedule

1:15 PM - 1:27 PM

[30-416-pm01S] Altered therapeutic activity of antiepileptic compounds involving the TrkB, a receptor for brain-derived neurotrophic factor

○Yuu Kobayashi¹, Chika Aoe¹, Misa Takenaka¹, Tetsuya Aiba² (1. Sch. Pharm. Sci., Okayama Univ., 2. Grad. Sch. Pharm. Sci., Okayama Univ.)

1:27 PM - 1:39 PM

[30-416-pm02] Production of NEU1 deficiency model mice and development of gene therapy

○Jun Tsukimoto¹, Rin Fukuike¹, Mizuki Miyoshi¹, Yuto Horii¹, Toshiki Iniwa¹, Nijiho Kamori¹, Yoshie Takeuchi¹, So-ichiro Nishioka¹, Noriko Tarashima¹, Noriaki Minakawa¹, Kohji Itoh² (1. Tokushima Univ., 2. Jichi Med. Univ.)

1:39 PM - 1:51 PM

[30-416-pm03S] A new method for spinal cord astrocyte isolation using ACSA2 antibody and cold active protease

○Ryoma Iwasaki¹, Yuta Kohro¹, Makoto Tsuda¹ (1. Grad. Sch. Pharm. Sci., Kyushu Univ.)

1:51 PM - 2:03 PM

[30-416-pm04S] The role of sphingomyelin in the modulation of astrocyte activation

○Ryo Kadowaki¹, Takuya Honda¹, Hiroyuki Nakamura¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ.)

2:03 PM - 2:15 PM

[30-416-pm05S] Regulation of the p73 signaling pathway by Nitric oxide

○Kota Ogawa¹, Sho Kubota¹, Nobumasa Takasugi¹, Takashi Uehara¹ (1. Grad. Sch. Med. Dent. Pharma. Sci. Okayama Univ.)